PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcumen Pharmaceuticals
Acumen Pharmaceuticals(ABOS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Histone-arginine methyltransferase carm1
pancreatic neoplasms
Surlorian
healthy volunteers/patients
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
triple negative breast neoplasms
,
head and neck neoplasms
,
melanoma
,
parkinson disease
,
myeloid leukemia acute
,
carcinoma
,
large b-cell lymphoma diffuse
,
acute kidney injury
,
follicular lymphoma
,
liver cirrhosis
,
fibrosis
,
hepatitis c
,
chronic hepatitis c
,
hepacivirus
,
vascular surgical procedures
,
wounds and injuries
,
recurrence
,
non-hodgkin lymphoma
,
hairy cell leukemia
,
b-cell chronic lymphocytic leukemia
,
b-cell lymphoma marginal zone
,
pancreatic neoplasms
,
neoplasm metastasis
,
adenocarcinoma
,
urologic neoplasms
,
transitional cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
multiple myeloma
,
myelodysplastic syndromes
,
plasma cell neoplasms
,
ovarian neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
preleukemia
,
syndrome
,
takayasu arteritis
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
psoriasis
SABIRNETUG
alzheimer disease
,
memory disorders
,
cognitive dysfunction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use